Application 200823
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 500MG;EQ 15MG BASE | No | No |
| 002 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 850MG;EQ 15MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 57237-217 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-217 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-217 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-217 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-218 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-218 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-218 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-218 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 65862-525 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-525 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-525 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-525 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-526 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-526 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-526 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-526 | Pioglitazone Hydrochloride and Metformin Hydrochloride | Pioglitazone Hydrochloride and Metformin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |